EMC Capital Management - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
EMC Capital Management ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$333
-13.1%
28,4830.0%0.24%
-17.8%
Q2 2023$383
-18.9%
28,4830.0%0.30%
-25.2%
Q1 2023$472
-10.9%
28,4830.0%0.40%
-16.6%
Q4 2022$530
-99.9%
28,4830.0%0.48%
+40.8%
Q3 2022$365,000
+82.5%
28,4830.0%0.34%
+97.7%
Q2 2022$200,000
-47.6%
28,483
-43.2%
0.17%
-37.4%
Q1 2022$382,00050,1430.27%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders